Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Antifungal activity against Candida species of the selective serotonin-reuptake inhibitor, sertraline.

Lass-Flörl C, Dierich MP, Fuchs D, Semenitz E, Ledochowski M.

Clin Infect Dis. 2001 Dec 15;33(12):E135-6. Epub 2001 Nov 7.

PMID:
11700578
2.

Treatment of premenstrual dysphoric disorder with luteal phase dosing of sertraline.

Halbreich U, Kahn LS.

Expert Opin Pharmacother. 2003 Nov;4(11):2065-78. Review.

PMID:
14596660
3.

The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders.

MacQueen G, Born L, Steiner M.

CNS Drug Rev. 2001 Spring;7(1):1-24. Review.

4.

Premenstrual dysphoria and the serotonin system: pathophysiology and treatment.

Steiner M, Pearlstein T.

J Clin Psychiatry. 2000;61 Suppl 12:17-21. Review.

5.

Treatment of premenstrual dysphoric disorder with selective serotonin reuptake inhibitors.

Luisi AF, Pawasauskas JE.

Pharmacotherapy. 2003 Sep;23(9):1131-40. Review.

PMID:
14524645
6.

Selective serotonin reuptake inhibitors and treatment of premenstrual dysphoric disorder.

Finfgeld DL.

Perspect Psychiatr Care. 2002 Apr-Jun;38(2):50-60. Review.

PMID:
12132631
7.

SSRIs for premenstrual dysphoric disorder.

[No authors listed]

Drug Ther Bull. 2002 Sep;40(9):70-2. Review.

PMID:
12298224
8.

[Psychiatric and psychological aspects of premenstrual syndrome].

Limosin F, Ades J.

Encephale. 2001 Nov-Dec;27(6):501-8. Review. French.

PMID:
11865558
9.

Treating premenstrual dysphoric disorder using serotonin agents.

Lin J, Thompson DS.

J Womens Health Gend Based Med. 2001 Oct;10(8):745-50. Review.

PMID:
11703886
10.

Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs.

Steiner M, Pearlstein T, Cohen LS, Endicott J, Kornstein SG, Roberts C, Roberts DL, Yonkers K.

J Womens Health (Larchmt). 2006 Jan-Feb;15(1):57-69. Review.

PMID:
16417420
11.

Review of fluoxetine and its clinical applications in premenstrual dysphoric disorder.

Pearlstein T, Yonkers KA.

Expert Opin Pharmacother. 2002 Jul;3(7):979-91. Review.

PMID:
12083997
12.

Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitors.

Nair GV, Gurbel PA, O'Connor CM, Gattis WA, Murugesan SR, Serebruany VL.

Am J Cardiol. 1999 Aug 1;84(3):321-3, A8. Review.

PMID:
10496443
13.

Treatment of premenstrual dysphoria with selective serotonin re-uptake inhibitors: focus on safety.

Macdougall M, Steiner M.

Expert Opin Drug Saf. 2003 Mar;2(2):161-6. Review.

PMID:
12904116
15.

Patient information. What is premenstrual dysphoric disorder (PMDD)?

[No authors listed]

Cleve Clin J Med. 2004 Apr;71(4):322. Review. No abstract available.

PMID:
15117172
16.

[Selective serotonin reuptake inhibitors--current knowledge].

Dudek D, Zieba A, Siwek M, Wróbel A.

Psychiatr Pol. 2004 May-Jun;38(3):507-24. Review. Polish.

PMID:
15199659
17.

Premenstrual dysphoric disorder in adolescents: case reports of treatment with fluoxetine and review of the literature.

Silber TJ, Valadez-Meltzer A.

J Adolesc Health. 2005 Dec;37(6):518-25. Review.

PMID:
16310133
18.

[Vulvovaginal candidiasis: a therapeutic approach].

Battaglia F, Mariani L, Anglana F, Milite V, Quattrini M, Plotti F, Tomao F, Plotti G.

Minerva Ginecol. 2005 Apr;57(2):131-9. Review. Italian.

PMID:
15940073
19.

Recurrent vulvovaginal candidiasis.

Ringdahl EN.

Mo Med. 2006 Mar-Apr;103(2):165-8. Review.

PMID:
16703718
20.

Diagnosis and treatment of premenstrual dysphoric disorder.

Bhatia SC, Bhatia SK.

Am Fam Physician. 2002 Oct 1;66(7):1239-48. Review.

Supplemental Content

Support Center